Scholars Central

Research articlePublished 7 Sep 2021

The AAV Vector as a SMA Disease Modifier

Authors: Ana Cristina Martins De Figueiredo

Advancements in Genetic Engineering

Volume 10 · Issue 4 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The discovery of DNA as the biomolecule of genetic inheritance and disease opened the prospect of therapies in which mutant and damaged genes could be altered for the improvement of the human condition.1,2 Genome-editing is a technology that allows specific changes in the genes of interest. This approach is capable of manipulating the genome of living cells or organisms in various ways: insertions or deletions of chosen genes, introduction of point mutations, knockout or correction of specific genes3 Gene therapy provides a unique approach to treat a variety of both inherited and acquired diseases2 by delivering a therapeutic gene material to correct the loss‐of‐ function caused by mutation or to express the deficient gene product.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advancements in Genetic Engineering.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvancements in Genetic Engineering
  • SubjectGenetics & Molecular Biology
  • SubjectEngineering
  • BylineArticles whose byline prints “Ana Cristina Martins De Figueiredo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels